Inhaled Corticosteroid Plus Long-Acting Beta2-Agonist Therapy Is Overused In The Treatment Of Patients With Chronic Obstructive Pulmonary Disease: Post Hoc Analyses Of Two 1-Year Studies

Pulmonary Disease ◽

Chronic Obstructive ◽

Inhaled Corticosteroid ◽

Agonist Therapy ◽

Long Acting ◽

Post Hoc ◽

P123 Inhaled corticosteroid plus long-acting β2-agonist therapy is overused in the treatment of patients with chronic obstructive pulmonary disease: post hoc analyses of two 1-year studies: Abstract P123 Table 1

Thorax ◽

10.1136/thoraxjnl-2015-207770.260 ◽

2015 ◽

Vol 70 (Suppl 3) ◽

pp. A137.1-A137 ◽

Cited By ~ 1

Author(s):

H Watz ◽

GT Ferguson ◽

L Grönke ◽

F Voß ◽

R Abrahams ◽

...

Keyword(s):

Pulmonary Disease ◽

Chronic Obstructive ◽

Inhaled Corticosteroid ◽

Agonist Therapy ◽

Long Acting ◽

Post Hoc ◽

Β2 Agonist

Risk of pneumonia with inhaled corticosteroid/long-acting β2 agonist therapy in chronic obstructive pulmonary disease: a cluster analysis

International Journal of Chronic Obstructive Pulmonary Disease ◽

10.2147/copd.s60498 ◽

2014 ◽

pp. 457 ◽

Cited By ~ 18

Author(s):

Rachael DiSantostefano ◽

Hao Li ◽

David Hinds ◽

Dmitry Galkin ◽

David Rubin

Keyword(s):

Cluster Analysis ◽

Pulmonary Disease ◽

Chronic Obstructive ◽

Inhaled Corticosteroid ◽

Agonist Therapy ◽

Beta 2 ◽

Long Acting

Effect of Adding Inhaled Corticosteroid to Long-Acting Muscarinic Antagonist/Long-Acting Beta-Agonist Therapy Among Patients With Chronic Obstructive Pulmonary Disease

Cureus ◽

10.7759/cureus.19168 ◽

2021 ◽

Author(s):

Mizuki Yuasa ◽

Yosuke Tanaka ◽

Tohru Tanaka ◽

Takeru Kashiwada ◽

Namiko Taniuchi ◽

...

Keyword(s):

Pulmonary Disease ◽

Beta Agonist ◽

Chronic Obstructive ◽

Inhaled Corticosteroid ◽

Agonist Therapy ◽

Muscarinic Antagonist ◽

Long Acting

In people with chronic obstructive pulmonary disease, how does combination inhaled corticosteroid and long-acting beta2-agonist compare with tiotropium at improving outcomes?

Cochrane Clinical Answers ◽

10.1002/cca.26 ◽

2012 ◽

Keyword(s):

Pulmonary Disease ◽

Chronic Obstructive ◽

Inhaled Corticosteroid ◽

Long Acting ◽

Comparative Effectiveness of Long-Acting Beta2-Agonist Combined with a Long-Acting Muscarinic Antagonist or Inhaled Corticosteroid in Chronic Obstructive Pulmonary Disease

Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ◽

10.1002/phar.1913 ◽

2017 ◽

Vol 37 (4) ◽

pp. 447-455 ◽

Cited By ~ 8

Author(s):

Jennifer C. Samp ◽

Min J. Joo ◽

Glen T. Schumock ◽

Gregory S. Calip ◽

A. Simon Pickard ◽

...

Keyword(s):

Pulmonary Disease ◽

Comparative Effectiveness ◽

Chronic Obstructive ◽

Inhaled Corticosteroid ◽

Muscarinic Antagonist ◽

Long Acting ◽

Characteristics of Patients with Chronic Obstructive Pulmonary Disease (COPD) Receiving Inhaled Corticosteroid/Long-Acting b2-ß2-agonist (ICS/LABA) Fixed Combination Products in English Primary Care

Value in Health ◽

10.1016/j.jval.2013.08.252 ◽

2013 ◽

Vol 16 (7) ◽

pp. A366

Author(s):

B.T. Blak ◽

U. Rigney ◽

C. Emmas ◽

A. Hamblin

Keyword(s):

Primary Care ◽

Pulmonary Disease ◽

Fixed Combination ◽

Chronic Obstructive ◽

Inhaled Corticosteroid ◽

Long Acting

Combined aclidinium bromide and long-acting beta2-agonist for chronic obstructive pulmonary disease (COPD)

Cochrane Database of Systematic Reviews ◽

10.1002/14651858.cd011594.pub2 ◽

2018 ◽

Cited By ~ 3

Author(s):

Han Ni ◽

Soe Moe ◽

Zay Soe ◽

Kay Thi Myint ◽

K Neelakantan Viswanathan

Keyword(s):

Pulmonary Disease ◽

Chronic Obstructive ◽

Aclidinium Bromide ◽

Long Acting ◽

Combined corticosteroid and long-acting beta2 -agonist in one inhaler versus placebo for chronic obstructive pulmonary disease

Cochrane Database of Systematic Reviews ◽

10.1002/14651858.cd003794.pub4 ◽

2013 ◽

Cited By ~ 16

Author(s):

Luis Javier Nannini ◽

Phillippa Poole ◽

Stephen J Milan ◽

Rebecca Holmes ◽

Rebecca Normansell

Keyword(s):

Pulmonary Disease ◽

Chronic Obstructive ◽

Long Acting ◽

Combination inhaled steroid and long-acting beta2-agonist in addition to tiotropium versus tiotropium or combination alone for chronic obstructive pulmonary disease

10.1002/14651858.cd008532.pub2 ◽

2011 ◽

Cited By ~ 14

Author(s):

Charlotta Karner ◽

Christopher J Cates

Keyword(s):

Pulmonary Disease ◽

Chronic Obstructive ◽

Long Acting ◽

Impact of prior and concurrent medication on exacerbation risk with long-acting bronchodilators in chronic obstructive pulmonary disease: a post hoc analysis

Respiratory Research ◽

10.1186/s12931-019-1027-9 ◽

2019 ◽

Vol 20 (1) ◽

Cited By ~ 4

Author(s):

Ian Naya ◽

Lee Tombs ◽

David A. Lipson ◽

Isabelle Boucot ◽

Chris Compton

Keyword(s):

Pulmonary Disease ◽

Chronic Obstructive ◽

Post Hoc Analysis ◽

Exacerbation Risk ◽

Long Acting ◽

Post Hoc ◽

Concurrent Medication